---
title: New aspects in pediatric pulmonary hypertension - Commented 2022ERS/ESC-PH
  guidelines
date: '2023-11-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37963484/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231115170846&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Pulmonary hypertension (PH) in childhood differs from that of adulthood
  particularly in the specific pathophysiology of congenital heart disease-associated
  pulmonary arterial hypertension, the presence of developmental lung disease, and
  the frequent association with chromosomal, genetic, and syndromal abnormalities.
  Treatment of children with PH requires a modified diagnostic algorithm tailored
  to childhood, as well as pathophysiologically oriented therapeutic strategies. In
  the current ...
disable_comments: true
---
Pulmonary hypertension (PH) in childhood differs from that of adulthood particularly in the specific pathophysiology of congenital heart disease-associated pulmonary arterial hypertension, the presence of developmental lung disease, and the frequent association with chromosomal, genetic, and syndromal abnormalities. Treatment of children with PH requires a modified diagnostic algorithm tailored to childhood, as well as pathophysiologically oriented therapeutic strategies. In the current ...